Plasma TNF-a level at 0, 4, 8 weeks
Showing 1 - 25 of >10,000
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
SCN2A Encephalopathy, SCN8A Encephalopathy Trial in Tacoma (Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks, Part A: 0.5mg/kg/day
Recruiting
- SCN2A Encephalopathy
- SCN8A Encephalopathy
- Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks
- +2 more
-
Tacoma, WashingtonPraxis Research Site
Apr 18, 2023
Depression, Anxiety Trial in Regina (Wellbeing Course for Students (Fast Track), Wellbeing Course for Students (5 weeks),
Recruiting
- Depression
- Anxiety
- Wellbeing Course for Students (Fast Track)
- +2 more
-
Regina, Saskatchewan, CanadaOnline Therapy Unit, University of Regina
Sep 20, 2022
A Real-World Evidence Long-Term Follow-Up Study to Assess
Not yet recruiting
- Aphakia
- AcrySof single-piece IOL
- AcrySof multi-piece IOL
- (no location specified)
Mar 23, 2023
Asthma, Allergic Trial in Hamilton, Saskatoon (Tezepelumab, Placebo)
Not yet recruiting
- Asthma, Allergic
- Tezepelumab
- Placebo
-
Hamilton, Ontario, Canada
- +1 more
Feb 22, 2023
Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)
Active, not recruiting
- Influenza, Human
- GSK4382276A Dose level 1
- +4 more
-
Edegem, Belgium
- +6 more
Jan 9, 2023
The Right Care, for Right Patient, at Right Time, by Right
Not yet recruiting
- Ambulatory Care
- +3 more
- On-site recruitment (information and consent) following a random sampling recruitment schedule
- +2 more
-
Kingston, Ontario, Canada
- +6 more
May 26, 2023
Postpartum Depression Trial in Egham (Baseline Assessment, Brief Online ACT Intervention, Post-Intervention Assessment (i.e.
Completed
- Postpartum Depression
- Baseline Assessment
- +3 more
-
Egham, Surrey, United KingdomRoyal Holloway University of London
May 13, 2022
Enteral Nutrition Trial in Calgary (Early exclusive enteral nutrition)
Recruiting
- Enteral Nutrition
- Early exclusive enteral nutrition
-
Calgary, Alberta, Canada
- +2 more
Dec 19, 2021
Atopic Dermatitis, Plaque Psoriasis Trial (PF-07038124 ointment 0.01%, Vehicle ointment, PF-07038124 ointment 0.03%)
Recruiting
- Atopic Dermatitis
- Plaque Psoriasis
- PF-07038124 ointment 0.01%
- +3 more
-
Encinitas, California
- +31 more
Jan 23, 2023
Dental Caries Trial in Puerto Rico, United States (0.24% Sodium Fluoride Dentifrice, 1.5% Arginine Dentifrice, 4.0% Arginine
Recruiting
- Dental Caries
- 0.24% Sodium Fluoride Dentifrice
- +3 more
-
Loma Linda, California
- +8 more
Sep 21, 2022
Meningococcal Invasive Infections at Participating Centers
Recruiting
- Invasive Meningococcal Disease
- surveillance
-
Calgary, Alberta, Canada
- +12 more
Apr 4, 2022
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)
Recruiting
- Hidradenitis Suppurativa
- Lutikizumab
- Placebo
-
Phoenix, Arizona
- +54 more
Jan 26, 2023
HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since
Completed
- HIV
- DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
- +2 more
-
Badalona, Barcelona, SpainIrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Fabry Disease Trial in Worldwide (Pegunigalsidase alfa)
Completed
- Fabry Disease
- Pegunigalsidase alfa
-
Birmingham, Alabama
- +20 more
Mar 29, 2022
Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia
Recruiting
- Myelodysplastic Syndrome
- +2 more
- Navitoclax
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023
Ulcerative Colitis Trial in Worldwide (Etrolizumab, Infliximab, Placebo (IV))
HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,
Recruiting
- HIV Infection
- ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
- Normal saline solution
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Jul 11, 2022
Colonic Polyp, Colorectal Polyp, Colorectal Adenoma Trial in United Kingdom (GI Genius-assisted diagnostic colonoscopy,
Recruiting
- Colonic Polyp
- +6 more
- GI Genius-assisted diagnostic colonoscopy
- Diagnostic Colonoscopy
-
Hartlepool, County Durham, United Kingdom
- +9 more
Oct 28, 2022
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022